{"id":3994,"date":"2023-09-19T08:44:46","date_gmt":"2023-09-19T08:44:46","guid":{"rendered":"https:\/\/www.sygnaturediscovery.com\/poster\/characterising-the-response-of-tumours-to-fractioned-radiotherapy-and-immune-checkpoint-inhibitors\/"},"modified":"2026-01-22T17:16:20","modified_gmt":"2026-01-22T17:16:20","slug":"characterising-the-response-of-tumours-to-fractioned-radiotherapy-and-immune-checkpoint-inhibitors","status":"publish","type":"poster","link":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/characterising-the-response-of-tumours-to-fractioned-radiotherapy-and-immune-checkpoint-inhibitors\/","title":{"rendered":"Characterising the response of tumours to fractioned radiotherapy and immune checkpoint inhibitors"},"content":{"rendered":"<p>Do you want to know how radiotherapy and immunotherapy can work together to fight cancer?<\/p>\n<p>In our latest poster, we explored the effects of different doses and schedules of radiation in combination with immune checkpoint inhibitors on tumour growth in a syngeneic mouse model of colorectal cancer.<\/p>\n<p>We tested the combination of radiation with immune checkpoint inhibitors and found that fractionated radiation, which is delivered in smaller doses over several days, was more effective and tolerable than a single high dose. With the use of flow cytometry, we characterised the changes in the tumour microenvironment and revealed how radiation and immunotherapy can alter the balance of the infiltrated immune cells.<\/p>\n<p>Our work provides valuable insights into the mechanisms and outcomes of combining radiotherapy and immunotherapy for cancer treatment. It also offers a useful platform for testing new drugs and novel therapeutics that can potentially improve the efficacy and safety of this combination therapy.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>In our latest study, we delved into combining radiotherapy and immunotherapy against cancer. Fractionated radiation, given in smaller doses over several days, proved more effective and tolerable than a single high dose. Our work offers insights into this synergy, providing a platform to enhance the therapy&rsquo;s efficacy and safety.<\/p>\n","protected":false},"featured_media":2658,"template":"","category":[685,751,738,688],"class_list":["post-3994","poster","type-poster","status-publish","has-post-thumbnail","hentry","category-in-vivo-pharmacology","category-oncology","category-oncology-models","category-therapeutic-areas"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Fractionated vs Single-Dose Radiotherapy with Immunotherapy<\/title>\n<meta name=\"description\" content=\"Fractionated dosing outperformed a single high dose for efficacy and tolerability, with flow cytometry tracking immune shifts in a mouse tumor model.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/characterising-the-response-of-tumours-to-fractioned-radiotherapy-and-immune-checkpoint-inhibitors\/\" \/>\n<meta property=\"og:locale\" content=\"fr_CA\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Fractionated vs Single-Dose Radiotherapy with Immunotherapy\" \/>\n<meta property=\"og:description\" content=\"Fractionated dosing outperformed a single high dose for efficacy and tolerability, with flow cytometry tracking immune shifts in a mouse tumor model.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/characterising-the-response-of-tumours-to-fractioned-radiotherapy-and-immune-checkpoint-inhibitors\/\" \/>\n<meta property=\"og:site_name\" content=\"Sygnature\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-22T17:16:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/TO_EACR2023_IR-capability-poster-1-003-e1744810782784.png\" \/>\n\t<meta property=\"og:image:width\" content=\"888\" \/>\n\t<meta property=\"og:image:height\" content=\"628\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Estimation du temps de lecture\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/poster\\\/characterising-the-response-of-tumours-to-fractioned-radiotherapy-and-immune-checkpoint-inhibitors\\\/\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/poster\\\/characterising-the-response-of-tumours-to-fractioned-radiotherapy-and-immune-checkpoint-inhibitors\\\/\",\"name\":\"Fractionated vs Single-Dose Radiotherapy with Immunotherapy\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/poster\\\/characterising-the-response-of-tumours-to-fractioned-radiotherapy-and-immune-checkpoint-inhibitors\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/poster\\\/characterising-the-response-of-tumours-to-fractioned-radiotherapy-and-immune-checkpoint-inhibitors\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/TO_EACR2023_IR-capability-poster-1-003-e1744810782784.png\",\"datePublished\":\"2023-09-19T08:44:46+00:00\",\"dateModified\":\"2026-01-22T17:16:20+00:00\",\"description\":\"Fractionated dosing outperformed a single high dose for efficacy and tolerability, with flow cytometry tracking immune shifts in a mouse tumor model.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/poster\\\/characterising-the-response-of-tumours-to-fractioned-radiotherapy-and-immune-checkpoint-inhibitors\\\/#breadcrumb\"},\"inLanguage\":\"fr-CA\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/poster\\\/characterising-the-response-of-tumours-to-fractioned-radiotherapy-and-immune-checkpoint-inhibitors\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/poster\\\/characterising-the-response-of-tumours-to-fractioned-radiotherapy-and-immune-checkpoint-inhibitors\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/TO_EACR2023_IR-capability-poster-1-003-e1744810782784.png\",\"contentUrl\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/TO_EACR2023_IR-capability-poster-1-003-e1744810782784.png\",\"width\":888,\"height\":628},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/poster\\\/characterising-the-response-of-tumours-to-fractioned-radiotherapy-and-immune-checkpoint-inhibitors\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Characterising the response of tumours to fractioned radiotherapy and immune checkpoint inhibitors\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/\",\"name\":\"Sygnature Discovery\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#organization\"},\"alternateName\":\"Sygnature\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-CA\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#organization\",\"name\":\"Sygnature Discovery\",\"alternateName\":\"Sygnature\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Logo.svg\",\"width\":1,\"height\":1,\"caption\":\"Sygnature Discovery\"},\"image\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.youtube.com\\\/@sygnature.discovery\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/sygnature-discovery\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Fractionated vs Single-Dose Radiotherapy with Immunotherapy","description":"Fractionated dosing outperformed a single high dose for efficacy and tolerability, with flow cytometry tracking immune shifts in a mouse tumor model.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/characterising-the-response-of-tumours-to-fractioned-radiotherapy-and-immune-checkpoint-inhibitors\/","og_locale":"fr_CA","og_type":"article","og_title":"Fractionated vs Single-Dose Radiotherapy with Immunotherapy","og_description":"Fractionated dosing outperformed a single high dose for efficacy and tolerability, with flow cytometry tracking immune shifts in a mouse tumor model.","og_url":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/characterising-the-response-of-tumours-to-fractioned-radiotherapy-and-immune-checkpoint-inhibitors\/","og_site_name":"Sygnature","article_modified_time":"2026-01-22T17:16:20+00:00","og_image":[{"width":888,"height":628,"url":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/TO_EACR2023_IR-capability-poster-1-003-e1744810782784.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Estimation du temps de lecture":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/characterising-the-response-of-tumours-to-fractioned-radiotherapy-and-immune-checkpoint-inhibitors\/","url":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/characterising-the-response-of-tumours-to-fractioned-radiotherapy-and-immune-checkpoint-inhibitors\/","name":"Fractionated vs Single-Dose Radiotherapy with Immunotherapy","isPartOf":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/characterising-the-response-of-tumours-to-fractioned-radiotherapy-and-immune-checkpoint-inhibitors\/#primaryimage"},"image":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/characterising-the-response-of-tumours-to-fractioned-radiotherapy-and-immune-checkpoint-inhibitors\/#primaryimage"},"thumbnailUrl":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/TO_EACR2023_IR-capability-poster-1-003-e1744810782784.png","datePublished":"2023-09-19T08:44:46+00:00","dateModified":"2026-01-22T17:16:20+00:00","description":"Fractionated dosing outperformed a single high dose for efficacy and tolerability, with flow cytometry tracking immune shifts in a mouse tumor model.","breadcrumb":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/characterising-the-response-of-tumours-to-fractioned-radiotherapy-and-immune-checkpoint-inhibitors\/#breadcrumb"},"inLanguage":"fr-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.sygnaturediscovery.com\/fr\/poster\/characterising-the-response-of-tumours-to-fractioned-radiotherapy-and-immune-checkpoint-inhibitors\/"]}]},{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/characterising-the-response-of-tumours-to-fractioned-radiotherapy-and-immune-checkpoint-inhibitors\/#primaryimage","url":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/TO_EACR2023_IR-capability-poster-1-003-e1744810782784.png","contentUrl":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/TO_EACR2023_IR-capability-poster-1-003-e1744810782784.png","width":888,"height":628},{"@type":"BreadcrumbList","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/characterising-the-response-of-tumours-to-fractioned-radiotherapy-and-immune-checkpoint-inhibitors\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.sygnaturediscovery.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Characterising the response of tumours to fractioned radiotherapy and immune checkpoint inhibitors"}]},{"@type":"WebSite","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#website","url":"https:\/\/www.sygnaturediscovery.com\/fr\/","name":"Sygnature Discovery","description":"","publisher":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#organization"},"alternateName":"Sygnature","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.sygnaturediscovery.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-CA"},{"@type":"Organization","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#organization","name":"Sygnature Discovery","alternateName":"Sygnature","url":"https:\/\/www.sygnaturediscovery.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Logo.svg","contentUrl":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Logo.svg","width":1,"height":1,"caption":"Sygnature Discovery"},"image":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.youtube.com\/@sygnature.discovery","https:\/\/www.linkedin.com\/company\/sygnature-discovery\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/poster\/3994","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/poster"}],"about":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/types\/poster"}],"version-history":[{"count":0,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/poster\/3994\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/media\/2658"}],"wp:attachment":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/media?parent=3994"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/category?post=3994"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}